Guggenheim Capital LLC raised its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 153.7% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 20,997 shares of the biotechnology company's stock after purchasing an additional 12,721 shares during the quarter. Guggenheim Capital LLC's holdings in Axon Enterprise were worth $12,479,000 at the end of the most recent quarter.
Other institutional investors and hedge funds also recently bought and sold shares of the company. Vanguard Group Inc. increased its position in Axon Enterprise by 3.4% during the fourth quarter. Vanguard Group Inc. now owns 8,446,437 shares of the biotechnology company's stock worth $5,019,886,000 after buying an additional 275,959 shares during the last quarter. Geode Capital Management LLC raised its stake in shares of Axon Enterprise by 3.7% in the fourth quarter. Geode Capital Management LLC now owns 1,847,925 shares of the biotechnology company's stock valued at $1,095,542,000 after acquiring an additional 65,097 shares during the last quarter. Alliancebernstein L.P. grew its holdings in Axon Enterprise by 273.8% during the 4th quarter. Alliancebernstein L.P. now owns 1,109,045 shares of the biotechnology company's stock worth $659,128,000 after acquiring an additional 812,337 shares during the last quarter. Norges Bank bought a new stake in shares of Axon Enterprise during the fourth quarter worth $482,081,000. Finally, GQG Partners LLC bought a new stake in shares of Axon Enterprise during the fourth quarter worth approximately $478,349,000. Hedge funds and other institutional investors own 79.08% of the company's stock.
Analyst Upgrades and Downgrades
Several research firms have weighed in on AXON. Northcoast Research lowered shares of Axon Enterprise from a "buy" rating to a "neutral" rating in a report on Wednesday, February 19th. Barclays reiterated a "hold" rating on shares of Axon Enterprise in a research note on Monday, March 10th. TD Cowen assumed coverage on shares of Axon Enterprise in a research report on Wednesday, January 8th. They set a "buy" rating and a $700.00 price target on the stock. JMP Securities reissued an "outperform" rating on shares of Axon Enterprise in a research report on Tuesday, February 4th. Finally, Craig Hallum lowered Axon Enterprise from a "buy" rating to a "cautious" rating in a report on Monday, March 10th. One research analyst has rated the stock with a sell rating, two have issued a hold rating and ten have issued a buy rating to the company. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $626.45.
Check Out Our Latest Stock Analysis on Axon Enterprise
Axon Enterprise Price Performance
NASDAQ:AXON traded down $12.32 during mid-day trading on Friday, hitting $559.53. 519,604 shares of the stock traded hands, compared to its average volume of 796,658. Axon Enterprise, Inc. has a 12-month low of $273.52 and a 12-month high of $715.99. The business's 50-day moving average price is $556.27 and its 200 day moving average price is $565.34. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The company has a market cap of $42.87 billion, a PE ratio of 144.58, a price-to-earnings-growth ratio of 5.17 and a beta of 1.13.
Insider Buying and Selling
In other news, Director Jeri Williams sold 307 shares of the stock in a transaction dated Monday, March 17th. The shares were sold at an average price of $552.72, for a total transaction of $169,685.04. Following the completion of the sale, the director now directly owns 1,627 shares in the company, valued at approximately $899,275.44. This represents a 15.87 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 6.10% of the stock is currently owned by corporate insiders.
About Axon Enterprise
(
Free Report)
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Recommended Stories

Before you consider Axon Enterprise, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Axon Enterprise wasn't on the list.
While Axon Enterprise currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Like this article? Share it with a colleague.
Link copied to clipboard.